Clinical Trial Update: Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fexofenadine HCl–pseudoephedrine HCl versus Allegra (fexofenadine) for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Allegra (fexofenadine)
• Allegra-D (fexofenadine/pseudoephedrine)

Snippet

Sponsor: Sanofi | Conditions: Rhinitis Seasonal | Phase 3 | Status: COMPLETED